Paul J. Clancy

Chief Financial Officer, Biogen.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Jun 30, 2026Granted 252 shares at $113.36 of Incyte8
  • Jun 8, 2026Granted 1,642 shares of Incyte11
  • May 19, 2026Sold 15,000 shares at $94.93 of Incyte12
  • May 19, 2026Exercised options 15,000 shares at $84.53 of Incyte12
  • Mar 31, 2026Granted 265 shares at $94.12 of Incyte13
  • Mar 23, 2026Returned to company 5,398 shares of Exact Sciences10
  • Mar 23, 2026Returned to company 20,640 shares of Exact Sciences10
  • Dec 31, 2025Granted 241 shares at $98.77 of Incyte14
  • Sep 30, 2025Granted 285 shares at $84.81 of Incyte15
  • Jun 30, 2025Granted 361 shares at $68.10 of Incyte16
  • Jun 12, 2025Granted 5,398 shares of Exact Sciences17
  • Jun 10, 2025Granted 2,518 shares of Incyte18
  • Mar 31, 2025Granted 358 shares at $60.55 of Incyte19
  • Dec 31, 2024Granted 331 shares at $69.07 of Incyte20
  • Sep 30, 2024Granted 368 shares at $66.10 of Incyte21
  • Jun 28, 2024Granted 399 shares at $60.62 of Incyte22
  • Jun 13, 2024Granted 5,444 shares of Exact Sciences23
  • Jun 13, 2024Granted 5,939 shares of Exact Sciences24
  • Jun 12, 2024Granted 2,830 shares of Incyte25
  • Mar 28, 2024Granted 403 shares at $56.97 of Incyte26
  • Dec 29, 2023Granted 412 shares at $62.79 of Incyte27
  • Sep 29, 2023Granted 379 shares at $57.77 of Incyte28
  • Jun 30, 2023Granted 380 shares at $62.25 of Incyte29
  • Jun 14, 2023Granted 2,505 shares of Incyte30
  • Jun 8, 2023Granted 3,599 shares of Exact Sciences31